메뉴 건너뛰기
Lancet
Volumn 370, Issue 9603, 2007, Pages 1905-
CAIRO and FOCUS - Authors' reply
Author keywords

[No Author keywords available]
Indexed keywords

FLUOROURACIL;
EID: 36549062523     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61808-X     Document Type: Letter
Times cited : (1)
References (2)
  • 1
    • 34249000361 scopus 로고    scopus 로고
    • Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest
    • Falcone A., Ricci S., Brunetti I., et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25 (2007) 1670-1676
    • (2007) J Clin Oncol , vol.25 , pp. 1670-1676
    • Falcone, A.1    Ricci, S.2    Brunetti, I.3
  • 2
    • 36849016055 scopus 로고    scopus 로고
    • A pooled safety and efficay analysis examining the effect of performance status on outcomes in first-line treatment trials of 6286 patients with metastatic colorectal cancer
    • Goldberg R., Kohne C., Seymour M., et al. A pooled safety and efficay analysis examining the effect of performance status on outcomes in first-line treatment trials of 6286 patients with metastatic colorectal cancer. J Clin Oncol 25 suppl 18S (2007) 166s
    • (2007) J Clin Oncol , vol.25 , Issue.SUPPL. 18S
    • Goldberg, R.1    Kohne, C.2    Seymour, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.